Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 87

1.

Plasma ghrelin levels and weight loss in Chinese Uygur patients with chronic obstructive pulmonary disease.

Ying BW, Song XB, Fan H, Wang LL, Li YS, Cheng Z, Cheng H, Wen FQ.

J Int Med Res. 2008 Nov-Dec;36(6):1371-7.

PMID:
19094448
2.

Elevated plasma ghrelin level in underweight patients with chronic obstructive pulmonary disease.

Itoh T, Nagaya N, Yoshikawa M, Fukuoka A, Takenaka H, Shimizu Y, Haruta Y, Oya H, Yamagishi M, Hosoda H, Kangawa K, Kimura H.

Am J Respir Crit Care Med. 2004 Oct 15;170(8):879-82. Epub 2004 Jul 21.

PMID:
15271696
3.

Serum ghrelin and adiponectin levels are increased but serum leptin level is unchanged in low weight Chronic Obstructive Pulmonary Disease patients.

Uzum AK, Aydin MM, Tutuncu Y, Omer B, Kiyan E, Alagol F.

Eur J Intern Med. 2014 Apr;25(4):364-9. doi: 10.1016/j.ejim.2013.02.012. Epub 2013 Mar 21.

PMID:
23523152
4.

[Circulating leptin and ghrelin in patients with chronic obstructive pulmonary disease].

Peng M, Cai BQ, Ma Y, Zhu HJ, Sun Q, Song AL.

Zhonghua Jie He He Hu Xi Za Zhi. 2007 Mar;30(3):182-5. Chinese.

PMID:
17572996
5.

[The changes of ghrelin, growth hormone, growth hormone releasing hormone and their clinical significances in patients with chronic obstructive pulmonary disease].

Xu ZS, Bao ZY, Wang ZY, Yang GJ, Zhu DF, Zhang L, Tan RM.

Zhonghua Nei Ke Za Zhi. 2012 Jul;51(7):536-9. Chinese.

PMID:
22943826
6.

Elevated circulating plasma adiponectin in underweight patients with COPD.

Tomoda K, Yoshikawa M, Itoh T, Tamaki S, Fukuoka A, Komeda K, Kimura H.

Chest. 2007 Jul;132(1):135-40.

PMID:
17625082
7.

Circulating ghrelin in patients with chronic obstructive pulmonary disease.

Luo FM, Liu XJ, Li SQ, Wang ZL, Liu CT, Yuan YM.

Nutrition. 2005 Jul-Aug;21(7-8):793-8.

PMID:
15975486
8.

[Serum ghrelin, IL-6 and TNF-α levels in patients with chronic obstructive pulmonary disease.].

Deveci Y, Deveci F, Ilhan N, Karaca I, Turgut T, Muz MH.

Tuberk Toraks. 2010;58(2):162-72. Turkish.

PMID:
20865569
9.

Nutritional status is related to fat-free mass, exercise capacity and inspiratory strength in severe chronic obstructive pulmonary disease patients.

Sabino PG, Silva BM, Brunetto AF.

Clinics (Sao Paulo). 2010 Jun;65(6):599-605. doi: 10.1590/S1807-59322010000600007.

10.

Whole-body resting and exercise-induced lipolysis in sarcopenic [corrected] patients with COPD.

Franssen FM, Sauerwein HP, Rutten EP, Wouters EF, Schols AM.

Eur Respir J. 2008 Dec;32(6):1466-71. doi: 10.1183/09031936.00014008. Epub 2008 Jun 25. Erratum in: Eur Respir J. 2009 Apr;33(4):947.

11.

Chronic obstructive pulmonary disease and body mass index in five Latin America cities: the PLATINO study.

Montes de Oca M, Tálamo C, Perez-Padilla R, Jardim JR, Muiño A, Lopez MV, Valdivia G, Pertuzé J, Moreno D, Halbert RJ, Menezes AM; PLATINO Team.

Respir Med. 2008 May;102(5):642-50. doi: 10.1016/j.rmed.2007.12.025. Epub 2008 Mar 7.

12.

The analyses of risk factors for COPD in the Li ethnic group in Hainan, People's Republic of China.

Ding Y, Xu J, Yao J, Chen Y, He P, Ouyang Y, Niu H, Tian Z, Sun P.

Int J Chron Obstruct Pulmon Dis. 2015 Nov 30;10:2593-600. doi: 10.2147/COPD.S86402. eCollection 2015.

13.

Ghrelin ameliorates catabolic conditions and respiratory dysfunction in a chronic obstructive pulmonary disease model of chronic cigarette smoke-exposed rats.

Kamiide Y, Inomata N, Furuya M, Yada T.

Eur J Pharmacol. 2015 May 15;755:88-94. doi: 10.1016/j.ejphar.2015.02.049. Epub 2015 Mar 11.

PMID:
25771457
14.
15.

Elevated circulating level of ghrelin in cachexia associated with chronic heart failure: relationships between ghrelin and anabolic/catabolic factors.

Nagaya N, Uematsu M, Kojima M, Date Y, Nakazato M, Okumura H, Hosoda H, Shimizu W, Yamagishi M, Oya H, Koh H, Yutani C, Kangawa K.

Circulation. 2001 Oct 23;104(17):2034-8.

16.

Nutritional status and long-term mortality in hospitalised patients with chronic obstructive pulmonary disease (COPD).

Hallin R, Gudmundsson G, Suppli Ulrik C, Nieminen MM, Gislason T, Lindberg E, Brøndum E, Aine T, Bakke P, Janson C.

Respir Med. 2007 Sep;101(9):1954-60. Epub 2007 May 25.

17.

Leptin, visfatin, insulin resistance, and body composition change in chronic obstructive pulmonary disease.

Eker S, Ayaz L, Tamer L, Ulubas B.

Scand J Clin Lab Invest. 2010 Feb;70(1):40-4. doi: 10.3109/00365510903484063.

PMID:
20021311
18.

Prognostic value of weight change in chronic obstructive pulmonary disease: results from the Copenhagen City Heart Study.

Prescott E, Almdal T, Mikkelsen KL, Tofteng CL, Vestbo J, Lange P.

Eur Respir J. 2002 Sep;20(3):539-44.

19.

Increased postabsorptive and exercise-induced whole-body glucose production in patients with chronic obstructive pulmonary disease.

Franssen FM, Sauerwein HP, Ackermans MT, Rutten EP, Wouters EF, Schols AM.

Metabolism. 2011 Jul;60(7):957-64. doi: 10.1016/j.metabol.2010.09.004. Epub 2010 Nov 5.

PMID:
21056887
20.

Expression of ghrelin in human salivary glands and its levels in saliva and serum in Chinese obese children and adolescents.

Li BB, Chen ZB, Li BC, Lin Q, Li XX, Li SL, Ding C, Wu LL, Yu GY.

Arch Oral Biol. 2011 Apr;56(4):389-94. doi: 10.1016/j.archoralbio.2010.10.014.

PMID:
21075359

Supplemental Content

Support Center